Mga aktibong sangkap na parmasyutiko
| Progestogen at estrogen | |||
| Pangalan ng produkto | Pagtukoy | Inaprubahan | CAS Hindi. |
| Progesterone | CP/EP/USP/JP | CEP/EU-GMP/FDA | 57-83-0 |
| Pagbubuntis | In-house |
Kosher | 145-13-1 |
| Medroxyprogesterone Acetate | CP/EP/USP/JP | DMF/GMP | 71-58-9 |
| Megestrol acetate | CP/EP/USP | DMF sa proseso | 595-33-5 |
| Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
| Cyproterone acetate | CP/EP/IP/KP | CEP/TGA/EU-GMP | 427-51-0 |
| Levonorgestrel | CP/EP/USP/IP | CEP/GMP | 797-63-7 |
| Norethisterone |
CP/EP/USP/JP |
DMF sa proseso |
68-22-4 |
| Norethisterone acetate |
EP/USP |
DMF sa proseso |
51-98-9 |
| Norethisterone Enanthate |
In-house |
Sa ilalim ng R&D |
3836-23-5 |
| Drospirenone | EP/USP | DMF | 67392-87-4 |
| Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
| Estradiol | CP/EP/USP/KP | DMF/GMP/WC | 35380-71-3 |
| Estriol | CP/EP/USP | Sa ilalim ng R&D | 50-27- 1 |
| Ethinyl estradiol | CP/EP/USP | GMP | 57-63-6 |
| Estradiol Valerate | CP/EP/USP/KP | DMF | 979-32-8 |
| Estradiol Cypionate |
USP | DMF sa proseso |
313-06-4 |
| Promestriene |
In-house |
Sa ilalim ng R&D |
39219-28-8 |
| Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
| Dienogest | EP | CEP/GMP | 65928-58-7 |
| Fulvestrant | EP/USP | Sa ilalim ng R&D | 129453-61-8 |
| Exemestane | CP/EP/USP | Sa ilalim ng R&D | 107868-30-4 |
| Androgen | |||
| Pangalan ng produkto | Pagtukoy | Inaprubahan | CAS Hindi. |
| Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
| Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
| Abiraterone acetate | CP/USP | DMF/GMP/WC | 154229-18-2 |
| Darolutamide |
In-house |
Sa ilalim ng R&D |
1297538-32-9 |
| Testosterone | CP/EP/USP | CEP/FDA/WC | 58-22-0 |
| Testosterone Undecanoate | CP | DMF/WC | 5949-44-0 |
| Testosterone Cypionate | USP | DMF | 58-20-8 |
| Testosterone Enanthate |
USP/JP | Sa ilalim ng R&D |
315-37-7 |
| Testosterone Propionate |
CP/EP/USP/JP |
Sa ilalim ng R&D |
57-85-2 |
| DHEA | FP/In-house | Dmf/wc/kosher | 53-43-0 |
| Clascoterone | In-house | DMF sa proseso | 19608-29-8 |
| Cortical hormone | |||
| Pangalan ng produkto | Pagtukoy | Inaprubahan | CAS Hindi. |
| Budesonide | CP/EP/USP/JP | CEP/FDA/GMP | 51333-22-3 |
| Desonide | CP/USP | DMF/GMP | 638-94-8 |
| Eplerenone | EP | Cep sa proseso | 107724-20-9 |
| Methylprednisolone | CP/EP/USP/JP | DMF/GMP | 83-43-2 |
| Methylprednisolone Hemisuccinate | CP/EP/USP | DMF/GMP | 2921-57-5 |
| Fluticasone Propionate | CP/EP/USP | DMF | 80474- 14-2 |
| Fluticasone furoate | CP/EP | DMF sa proseso | 397864-44-7 |
| Mometasone Furoate |
CP/EP/USP |
DMF sa proseso |
Anhydrous (83919-23-7) Monohydrate (141646-00-6) |
| Deflazacort |
In-house |
Sa ilalim ng R&D |
14484-47-0 |
| Iba | |||
| Pangalan ng produkto | Pagtukoy | Inaprubahan | CAS Hindi. |
| Oxcarbazepine | CP/EP/USP/IP | CEP/FDA/GMP | 28721-07-5 |
| Eslicarbazepine acetate | CP/USP | DMF | 236395- 14-5 |
| GANCICLOVIR | CP/EP/USP | DMF/GMP | 82410-32-0 |
| Valganciclovir Hydrochloride | USP/EP | Cep sa proseso | 175865-59-5 |
| Oseltamivir phosphate | CP/EP/USP | DMF | 204255- 11-8 |
| Baloxavir Marboxil | In-house | Sa ilalim ng R&D | 1985606-14-1 |
| Revefenacin | In-house | DMF | 864750-70-9 |
| Mirabegron | CP/EP | DMF | 223673-61-8 |
| Vibegron |
In-house |
Sa ilalim ng R&D |
1190389-15-1 |
| Escitalopram oxalate | CP/EP/USP | DMF sa proseso | 219861-08-2 |
| Citalopram hydrobromide |
CP/EP/USP |
DMF sa proseso |
59729-32-7 |
| Cariprazine Hydrochloride | In-house | DMF | 1083076-69-0 |
| Lasmiditan succinate | In-house | DMF | 439239-92-6 |
| Luliconazole | In-house | DMF | 187164-19-8 |
| Nintedanib esylate |
In-house |
FDA/DMF/WC |
656247-18-6 |
| Apalutami | In-house | DMF | 956104-40-8 |
| Tadalafil | CP/EP/USP | Sa ilalim ng R&D | 171596-29-5 |
| Relugolix | In-house | DMF sa proseso | 737789-87-6 |
| Ruxolitinib phosphate |
In-house |
DMF sa proseso |
1092939-17-7 |
| Abemaciclib |
In-house |
Sa ilalim ng R&D |
1231929-97-7 |
| Phloroglucinol | CP/EP | DMF | 108-73-6 |
| 1,3,5-trimethoxybenzene |
Cp/in-house |
GMP |
621-23-8 |
| Ursinoxycholic acid | EP/USP/JP | Sa ilalim ng R&D | 128-13-2 |
| Tauroursinoxycholic acid |
In-house |
Sa ilalim ng R&D |
14605-22-2 |
| Kolesterol |
CP/EP/USP/JP |
Sa ilalim ng R&D |
57-88-5 |
| Omega-3-acid ethyl eter 90 |
EP/USP |
DMF sa proseso |
—— |
| Medium-chain triglycerides |
CP/USP/EP |
DMF |
—— |
| Benzalkonium chloride |
USP/EP/JP |
Cep sa proseso |
8001-54-5 |
| Langis ng oliba (para sa iniksyon) |
CP/USP/EP/JP |
DMF sa proseso |
8001-25-0 |
| Egg phospholipids (para sa iniksyon) |
CP/USP/EP |
DMF |
93685-90-6 |
| Meryenda |
In-house |
DMF sa proseso |
203787-91-1 |
Para sa Methylprednisolone Hemisuccinate, mayroon kaming EP, USP at CP na detalye. Available ang DMF at WC.
Para sa Cyproterone Acetate (CPA), mayroon kaming mga detalye ng CP at EP, available ang CEP/TGA/EU-GMP.
Ang Levonorgestrel ay may mga detalye ng CP/EP/USP. Available ang DMF, GMP at CEP.
Ang Mifepristone ay may mga detalye ng CP at IP.DMF at naaprubahan ng GMP.
Sumusunod ang Tibolone sa detalye ng EP. Naaprubahan ang DMF.
Ang Estradiol Hemihydrate ay may detalye ng USP at EP. Available ang DMF.